Janney Montgomery Scott LLC bought a new stake in shares of Jefferies Financial Group Inc. (NYSE:JEF – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 4 ...
Get real-time NBA basketball coverage and scores as Charlotte Hornets takes on Orlando Magic. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...
1don MSN
The Eagles have entered their golden era. They’ve been to three Super Bowls in eight years, and now they’ve won two. They have talent to burn, but they have something else. Something more. Connection.
Get real-time NBA basketball coverage and scores as Charlotte Hornets takes on Brooklyn Nets. We bring you the latest game previews, live stats, and recaps on CBSSports.com ...
Guggenheim analyst Michael Schmidt maintained a Buy rating on Zentalis Pharmaceuticals (ZNTL – Research Report) yesterday and set a price ...
DUBLIN, Ohio, Jan. 30, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), a real estate technology ...
(Bloomberg) -- Jefferies Financial Group Inc. hired Tim Kerry from Barclays Plc as the bank builds up its ranks to prepare for a wave of M&A-related financings. Kerry will join Jefferies as co ...
With the House on recess this week, Minority Leader Hakeem Jeffries, D-N.Y., organized what he called an “emergency” virtual meeting with rank-and-file Democrats, set for 1 p.m. Wednesday ...
Nominally, their most important figures, and thus spokespeople, are congressional leaders like House Minority Leader Hakeem Jeffries and Senate Minority Leader Chuck Schumer. But caucus leaders ...
House Minority Leader Hakeem Jeffries put GOP leaders on notice Thursday that they can’t take Democratic votes for granted when it comes to lifting the statutory debt ceiling by this summer’s ...
Jefferies Financial Group Stock Down 1.3 % Shares of NYSE:JEF opened at $76.89 on Thursday. Jefferies Financial Group Inc. has a 52-week low of $39.58 and a 52-week high of $82.68. The stock has a ...
Jefferies has upgraded Crinetics Pharmaceuticals (NASDAQ:CRNX) to buy, citing a recent pullback in the stock on investor concerns about Phase 2 data for the company's drug atumelnant in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results